Literature DB >> 26471942

Cognitive function of youths born to mothers with opioid and poly-substance abuse problems during pregnancy.

Egil Nygaard1,2, Kari Slinning2,3, Vibeke Moe2,3, Kristine B Walhovd1,4.   

Abstract

Previous research has provided inconclusive evidence regarding the neuropsychological difficulties of children born to mothers partaking in opioid or poly-drug use during pregnancy. Little is known about how these children fare as they get older. The present longitudinal study includes follow-up data on 45 children born to mothers who used heroin and poly-drugs and a group of 48 children without prenatal drug exposure. Most of the drug-exposed youths were placed in permanent foster or adoptive homes before one year of age. The youths (ages 17 to 21) were administered 10 neuropsychological tests. The drug-exposed youths had cognitive and fine motor functions within the normal range compared to population norms but performed significantly worse than the non-exposed group. There were indications of generally lower cognitive functions rather than specific problems with executive functioning. Lower mean birthweight in the risk group (619 grams mean difference, p < .001) only partially mediated the group differences in cognitive functioning. There was a tendency for youths who had few and early changes in their caregivers or who were born to mothers who had used the least number of different drugs during pregnancy to have the best cognitive scores. The study indicates that youths born to mothers who used multiple drugs during pregnancy are vulnerable relative to their peers within a wide range of cognitive functions. The vulnerability seems to be related not only to the mother's drug use during pregnancy but also to factors such as birthweight and unstable parental care during infancy.

Entities:  

Keywords:  Adolescent; Cognitive function; Heroin; Poly-drug use; Prenatal drug exposure

Mesh:

Substances:

Year:  2015        PMID: 26471942     DOI: 10.1080/09297049.2015.1092509

Source DB:  PubMed          Journal:  Child Neuropsychol        ISSN: 0929-7049            Impact factor:   2.500


  15 in total

1.  Effects of opioid use in pregnancy on pediatric development and behaviour in children older than age 2: Systematic review.

Authors:  Stephanie Welton; Brittany Blakelock; Sharen Madden; Len Kelly
Journal:  Can Fam Physician       Date:  2019-12       Impact factor: 3.275

Review 2.  Opioid Use in Pregnancy.

Authors:  Amalia Londono Tobon; Erin Habecker; Ariadna Forray
Journal:  Curr Psychiatry Rep       Date:  2019-11-16       Impact factor: 5.285

3.  Prenatal opioid exposure inhibits microglial sculpting of the dopamine system selectively in adolescent male offspring.

Authors:  Caroline J Smith; Tania Lintz; Staci D Bilbo; Elena H Chartoff; Madeline J Clark; Karen E Malacon; Alia Abiad; Nicholas J Constantino; Veronica J Kim; Young C Jo; Yanaira Alonso-Caraballo
Journal:  Neuropsychopharmacology       Date:  2022-07-14       Impact factor: 8.294

4.  Generational Effects of Opioid Exposure.

Authors:  Katherine E Odegaard; Gurudutt Pendyala; Sowmya V Yelamanchili
Journal:  Encyclopedia (Basel, 2021)       Date:  2021-01-18

5.  Perinatal Morphine Exposure Leads to Sex-Dependent Executive Function Deficits and Microglial Changes in Mice.

Authors:  Brittany L Smith; Tess A Guzman; Alexander H Brendle; Collin J Laaker; Alexis Ford; Adam R Hiltz; Junfang Zhao; Kenneth D R Setchell; Teresa M Reyes
Journal:  eNeuro       Date:  2022-10-17

6.  Rates of substance and polysubstance use through universal maternal testing at the time of delivery.

Authors:  Brittany L Smith; Eric S Hall; Jennifer M McAllister; Michael P Marcotte; Kenneth D R Setchell; Vandana Megaraj; Kristine L Jimenez; T John Winhusen; Scott L Wexelblatt
Journal:  J Perinatol       Date:  2022-02-17       Impact factor: 3.225

Review 7.  Modeling prenatal opioid exposure in animals: Current findings and future directions.

Authors:  Elizabeth M Byrnes; Fair M Vassoler
Journal:  Front Neuroendocrinol       Date:  2017-09-28       Impact factor: 8.606

Review 8.  Prenatal opioid exposure and vulnerability to future substance use disorders in offspring.

Authors:  Yaa Abu; Sabita Roy
Journal:  Exp Neurol       Date:  2021-01-29       Impact factor: 5.330

Review 9.  Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling.

Authors:  Alexis L Franks; Kimberly J Berry; Donald B DeFranco
Journal:  J Neuroendocrinol       Date:  2019-10-02       Impact factor: 3.870

10.  Infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use.

Authors:  Madelyn H Labella; Rina D Eiden; Alexandra R Tabachnick; Tabitha Sellers; Mary Dozier
Journal:  Neurotoxicol Teratol       Date:  2021-06-08       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.